Bill
HR 1623
Overview: HR 1623, the "SCREEN Act", was introduced in the House on February 26, 2025.Purpose and Intent: The SCREEN Act (Securing Consistent Regulations for the Evaluation of Emer
Overview: HR 1623, the "SCREEN Act", was introduced in the House on February 26, 2025.
Purpose and Intent: The SCREEN Act (Securing Consistent Regulations for the Evaluation of Emerging Neurotechnology) aims to establish a comprehensive regulatory framework for the development and use of emerging neurotechnology products, such as brain-computer interfaces and neural implants.
Key Provisions:
- Requires the FDA to develop new safety and efficacy standards for neurotechnology devices.
- Mandates pre-market approval for all neurotechnology products before they can be sold or distributed.
- Establishes data privacy and security requirements for neurotechnology companies to protect user information.
- Creates a new advisory committee to provide expert guidance on neurotechnology regulation.
- Directs the FTC to develop rules prohibiting deceptive marketing of neurotechnology products.
Affected Parties and Impacts: The bill would primarily impact neurotechnology companies, researchers, and consumers. It aims to ensure the safe and responsible development of these emerging technologies while protecting user privacy and preventing misleading claims.
Procedural and Timeline Considerations: As the bill has just been introduced in the House, it will need to go through the full legislative process, including committee hearings, floor votes, and potential reconciliation with a Senate version before being sent to the President.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
